Uveal Melanoma
![Hepzato Kit, Delcath, Eye cancer, FDA approval, Uveal Melanoma](https://pharmtales.com/wp-content/uploads/2023/08/Delcath-Triumphs-After-Years-FDA-Grants-Approval-to-Hepzato-Kit-for-Treating-Metastatic-Uveal-Melanoma.jpg)
Delcath Triumphs After Years: FDA Grants Approval to Hepzato Kit for Treating Metastatic Uveal Melanoma
SG Tylor
After enduring nearly a decade of setbacks, Delcath has finally achieved a regulatory milestone in the United States. Delaware-based Delcath ...
![Novel BRG1BRM Inhibitor in Metastatic Uveal Melanoma Shows Safety and Preliminary Efficacy | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Novel-BRG1BRM-Inhibitor-in-Metastatic-Uveal-Melanoma-Shows-Safety-and-Preliminary-Efficacy.jpg)
Novel BRG1/BRM Inhibitor in Metastatic Uveal Melanoma Shows Safety and Preliminary Efficacy
SG Tylor
Source – Foghorn Therapeutics Foghorn Therapeutics has highlighted the safety and tolerability of FHD-286 in metastatic uveal melanoma (mUM) through ...